RP Bio Inc. (KOSDAQ: A314140)
Health Care · Pharmaceuticals · KR
₩5,590.00
-9.84% today · -9.8% 1Y
RP Bio Inc. (KOSDAQ: A314140) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $34.96M.
Over the last twelve months the share price has lost 9.8%, trading between 4.81K and 9.13K.
Tweenvest scores RP Bio Inc. across four factors: quality 70/100, value 73/100, growth 63/100. Its strongest factor is value.
A314140 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $34.96M
- Revenue (TTM)
- $91.32M
- P/E
- 7.19
- EPS
- 777.28
- Dividend yield
- —
- Beta (5Y)
- 0.41
- 52-week high
- ₩9,130.00
- 52-week low
- ₩4,810.00
- Avg volume (3M)
- —
- Shares outstanding
- 8.67M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,231.78 | -0.15% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $272.81 | -0.12% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $155.85 | -0.38% |
| Roche Holding AGSWX: ROP | $371.62B | CHF371.90 | -0.51% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.29 | -1.18% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.51 | -0.21% |
Figures last refreshed Aug 18, 2026.